20 March 2019 - - US-based biotechnology company Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA) has completed enrollment in two Phase 2 studies, the company said.

The Phase 2 study of EDP-938 in RSV is a randomised, double-blind, placebo-co...
20 March 2019 - - US-based Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) has submitted an Investigational New Drug application to the US Food and Drug Administration for an adaptive Phase 2/3 trial with the potential to serve as a pivotal registratio...
20 March 2019 - - US-based cancer diagnostics specialist laboratory CSI Laboratories has added the newly approved Ventana PD-L1 (SP142) Assay as a companion diagnostic test for use in selecting triple-negative breast cancer patients for Tencentriq (a...
20 March 2019 - - US-based clinical-stage biopharmaceutical company Cold Genesys, Inc has closed a USD 22m Series C preferred stock financing, the company said.

New investors participated in the round, including lead investor, ORI Health...
20 March 2019 - - US-based biopharmaceutical company Aimmune Therapeutics, Inc.'s (NASDAQ: AIMT) Biologics License Application for AR101 has been accepted for review by the US Food and Drug Administration.

Aimmune is developing AR10...